NASDAQ · SWKH
Financial Services · Asset Management
$15.90
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 11:56 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
SWKH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning SWKH.
SWKH research
Company profile and research snapshot.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 19, 2025 | Maxim Group | Buy | — |
| Apr 4, 2023 | Maxim Group | Buy | — |
No generated briefing is available yet.
seekingalpha.com · Dec 4, 2025
Stanley Black & Decker, Inc. (SWK) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SWKH.
